Neil Miller

Neil Miller currently serves as Senior Director of Early Oncology Clinical Science at AstraZeneca since April 2021. Prior to this role, Neil held the position of Consultant Clinical Scientist at Cambourne Consulting Limited, focusing on oncology and haematology early phase development from March 2016 to March 2021, with notable assignments in cell and gene therapies. Neil's experience also includes roles as Senior Clinical Scientist at Celgene from March 2013 to March 2016, Senior Clinical Trial Head within the Oncology Business Unit at Novartis Oncology from October 2005 to February 2013, Clinical Project Scientist at Takeda from May 2004 to September 2005, Clinical Study Leader at Eisai EMEA from March 1999 to October 2002, and Clinical Research Associate at Theorem from February 1997 to February 1999. Neil holds a Bachelor’s Degree in Pharmacology with Industrial Experience from The University of Manchester and a Master’s Degree in Experimental Therapeutics from the University of Oxford.